Axogen, Inc. Announces Positive Topline Results from Phase 3

Axogen, Inc.NASDAQ

Description

⋅ May 6, 2022 8:17 AM

AXGN: Axogen, Inc.
2022-05-04 16:01:00
Axogen, Inc. Announces Positive Topline Results from Phase 3 RECON(SM) Study for Avance® Nerve Graft